FindTrial
Sign In

Randomized Controlled Clinical Trial Simulation: Comparative Effectiveness Study of Cardiovascular Outcome Benefits of Simulated Hypoglycemic Agents in Type 2 Diabetes Patients with High Cardiovascular Risk Factors

Randomized Controlled Clinical Study Simulation: Comparative Effectiveness Study of Simulated Hypoglycemic Drugs on Cardiovascular Outcomes in Type 2 Diabetes Patients with Cardiovascular High-Risk Factors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111674
Enrollment
Unknown
Registered
2025-11-04
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

Type 2 Diabetes patients:NA

Sponsors

China National Key Laboratory of Pharmaceutical Regulatory Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of T2DM; 2. age >=18 years; 3. at least two records of hypoglycemic drug treatment involving one or more antidiabetic agents with intervals exceeding three months.

Exclusion criteria

Exclusion criteria: 1. Clinical diagnosis of type 1 diabetes mellitus; 2. History of malignancy.

Design outcomes

Primary

MeasureTime frame
Demographic characteristics;Clinical Characteristics;Treatment Patterns;Therapeutic outcome and prognosis;—

Countries

China

Contacts

Public ContactXin Xiaona

Center for Drug Evalution, NMPA

xinxn@cde.org.cn+86 10 6858 5566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026